CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation

BACKGROUND: Ulcerative colitis (UC) is a nonspecific inflammatory disease for which medications and therapeutic strategies have only been moderately successful. CBLB502, a toll-like receptor 5 (TLR5) agonist derived from Salmonella flagellin, exhibits anticancer and radioprotective activities via mo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Transl Med
Main Authors: Xu, Yang, Dong, Hongxia, Ge, Changhui, Gao, Yan, Liu, Haifeng, Li, Weiguang, Zhang, Chenggang
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5009027/
https://ncbi.nlm.nih.gov/pubmed/27668221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.08.25
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares